This panel will discuss collaboration in delivery development i.e., co-developing platforms, managing device timelines, and regulatory alignment in combo products.

• Strategies to leverage the speed and innovation of biotech startups alongside the deep experience and resources of pharma giants like AbbVie: turning potential clashes into powerful synergies
• What “we’re thoroughly enjoying our AbbVie relationship” means in practice: how both Ripple Therapeutics and AbbVie have fostered continuous learning and development through close cooperation during diligence, development planning, and execution phases
• The importance of proactive, transparent communication, and collaboration across functions, including early alignment with device teams and other stakeholders, to anticipate challenges and optimize program success